Entera Bio Ltd (ENTX) Social Stream
Entera Bio Ltd (ENTX) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering Entera Bio Ltd.
|Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
Over the past 131 days, ENTX's average price target has gone down $1.
Over the past 49 weeks, ENTX's average upside potential has been 173.77%.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
ENTX Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
Over the past 44 weeks, ENTX's average broker recommendation rating improved by 1.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- Entera Bio Ltd's number of analysts covering the stock is higher than 5.5% of Pharmaceutical Products stocks.
- Entera Bio Ltd's variance in analysts' estimates is lower than 83.56% of Pharmaceutical Products stocks.
- To contextualize these metrics, consider that out of Healthcare stocks, Entera Bio Ltd's average analyst price target is higher than 18.8% of them.
- In the context of Healthcare stocks, Entera Bio Ltd's upside potential (average analyst target price relative to current price) is greater than 78.67% of them.
Is ENTX a Buy, Hold or Sell? See the POWR Ratings now!